Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
Quick Find - Click to open on a page
HomeAbout MerckProductsNewsroomInvestor RelationsCareersResearchLicensingThe Merck Manuals
Contact Contact Licensing
PODCAST Podcast
RSS RSS

Licensing


Embracing Partnerships

Welcome! At Merck, we are strongly committed to partnership success. We recognize that the greatest achievements are not reached alone. They are the result of teamwork

We are serious about our commitment to strategic alliances. Our goal is to work together with our partners to remain in the forefront of turning scientific breakthroughs into medicines that make a difference.

We have established a clear path to partnering, and we invite you to explore the combining of your
strengths with ours, and the successes
we may share.


Mervyn Turner, Ph.D. Chief Strategy Officer and Senior Vice President of Worldwide Licensing and External Research“Most of the world’s biomedical research takes place outside of our laboratories, so we charge our scientists with building a 'virtual lab' – the blending of the best scientific programs from internal research and external collaborations. We want to help you take your great science and turn it into great medicine. We want to help you make a difference in the lives of patients all around the world. That’s why we are all in this together.”

Mervyn Turner, PhD
Chief Strategy Officer, Merck & Co., Inc., and
Senior Vice President, Worldwide Licensing and External Research
Merck Research Laboratories


Greg Wiederrecht, PhD, CLP“Merck’s scientists recognize that 99% of all discovery activity occurs outside of the company’s walls, and that it is a critical component of their roles to pay attention to what is going on throughout the world in their areas of expertise. They are charged with bringing the best compound forward, irrespective of whether it is identified at their bench or comes from the outside via a licensing arrangement.”

Greg Wiederrecht, PhD, CLP
Vice President and Head, External Scientific Affairs


Barbara Yanni, Chief Licensing Officer“Flexibility and creativity are critical components of our negotiation process. We’re interested in listening to you, to find the best way to bring your discovery through development to market.”

Barbara Yanni, JD, LLM, CLP
Vice President and Chief Licensing Officer







This Web site contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. more>>


*Software to view files presented in PDF or SWF format is available at no charge through the Adobe Web site. Get Adobe Reader Get Adobe Flash Player

Printer Friendly Page
 

Regional Contacts

We have regional contacts in The Americas, Europe, Asia, Middle East and Africa.

Featured Article

Opportunities to Partner Continue to Grow at Merck

Face-to-Face

Barbara Yanni
An exclusive interview with Barbara Yanni, Vice President and Chief Licensing Officer at Merck & Co

More Information

Embracing Partnerships, Committed to Partnering Success

Embracing Partnerships Video




Embracing Partnerships

 
Contact Merck Site Map Accessibility Statement Privacy Policy Terms of Use Copyright 1995-2008 Merck & Co., Inc.